Matt is a Research Felllow employed as part of the Centre for Biostatistics and affiliate of Manchester Clinical Trials Unit (MCTU). He is a keen advocate of novel clinical trial designs, transparency in clinical research, and use of novel technology to improve the quality and efficiency of clinical trials. The bulk of his experience is in musculoskeletal and oncology trials.

Matt has three main areas of focus for his research:

Novel trial designs that improve efficiency in clinical trials; particularly improving uptake and dissemination of novel methods. Examples include the use of appropriate interim analyses; Bayesian clinical trial designs; n-of-1 designs; and multi-arm adaptive designs. 

Choosing appropriate outcomes in chronic, painful conditions, in terms of sensitivity, validity, and reliability. Collection and analysis of patient-reported outcomes and subjective phenomena to take advantage of smart technology (smartphones and smartwatches).

Transparency in publishing: transparency and bias in meta-analyses, and improving transparency and reproducibility of analyses in clinical research, particularly through the use of literate programming.

2019 - PhD. The University of Manchester.

2008 - BSc (Hons) Psychology. The University of Liverpool.